期刊文献+

2018年~2019年杭州某医院肺炎克雷伯菌耐药性分析

Analysis of the Resistance of Klebsiella Pneumoniae in a Hospital in Hangzhou from 2018 to 2019
下载PDF
导出
摘要 目的回顾性分析某医院肺炎克雷伯菌的耐药现状,为临床治疗提供指导建议。方法收集某三甲医院2018年~2019年784株肺炎克雷伯菌,统计标本来源,采用VITEK^(■)2Compact全自动微生物分析仪对菌株进行鉴定和药敏试验,手工药敏试验采用K-B法,分析该院肺炎克雷伯菌耐药情况。结果784株肺炎克雷伯菌主要来源于痰液标本(50.51%)、其次是血液标本(15.22%)、尿液标本(13.91%),其他标本包括伤口、胆汁、排泄物、腹腔引流液、留置管和脓肿等(20.36%);2018年~2019年该院肺炎克雷伯菌总体耐药情况呈缓慢上升趋势;头孢菌素类药物中,对头孢唑林(46.82%)和头孢曲松(44.15%)耐药率较高,对头孢他啶(32.75%)、头孢吡肟(27.65%)和头孢替坦(22.05%)耐药率较低;碳青霉烯类药物中,对亚胺培南(24.05%)和美罗培南(23.00%)的耐药率较高,对厄他培南的耐药率较低(14.95%);氨基糖苷类药物中,对阿米卡星(17.75%)、庆大霉素(28.15%)和妥布霉素(21.75%)的耐药率较低,对环丙沙星(33.85%)和左氧氟沙星(33.10%)耐药率较高;未检出对替加环素耐药的肺炎克雷伯菌。结论该院分离的肺炎克雷伯菌的感染类型多样化,耐药情况较严重,呈缓慢上升趋势,并没有出现某些药物耐药率下降现象,因此应加大力度整治抗生素滥用现象。 Objective To retrospectively analyze the current status of drug resistance of Klebsiella pneumoniae in a hospital and provide guidance and recommendations for clinical treatment.Methods Collecting 784 strains of Klebsiella pneumoniae from 2018 to 2019 in a tertiary hospital,and count the source of the specimens.The VITEK^(■)2Compact automatic microbial analyzer was used to identify the strains and test for drug sensitivity.K-B method was used in manual drug susceptibility test to analyze the drug resistance of Klebsiella pneumonia in the hospital.Results 784 strains of Klebsiella pneumoniae were mainly derived from sputum specimens(50.51%),followed by blood specimens(15.22%),urine specimens(13.91%),and other specimens including wounds,bile,excreta,abdominal drainage,indwelling tube and abscess,etc.(20.36%);From 2018 to 2019,the overall resistance of Klebsiella pneumoniae in the hospital showed a slow upward trend;Among cephalosporins,the resistance rate to cefazolin(46.82%)and ceftriaxone(44.15%)was higher.Low resistance rate to ceftazidime(32.75%),cefepime(27.65%)and cefotetan(22.05%);Among carbapenem drugs,the resistance rate to imipenem(24.05%)and meropenem(23.00%)was higher,and the resistance rate to ertapenem was lower(14.95%);Among the aminoglycoside drugs,the resistance rate to amikacin(17.75%),gentamicin(28.15%)and tobramycin(21.75%)was low,and the resistance rate to ciprofloxacin(33.85%)and Levofloxacin(33.10%)had a higher resistance rate;Klebsiella pneumoniae resistant to tigecycline was not detected.Conclusion The infection types of Klebsiella pneumoniae isolated from this hospital are diversified,and the drug resistance is relatively serious,showing a slow upward trend.There is no decline in the drug resistance rate of certain drugs.Therefore,we should increase efforts to rectify the abuse of antibiotics.
作者 杜佳 DU Jia(Cancer Hospital of University of Chinese Academy of Sciences/Department of Laboratory Medicine,Zhejiang Cancer Hospital,Hangzhou 310000,Zhejiang,China;Institute of Basic Medicine and Cancer,Chinese Academy of Sciences,Hangzhou 310022,Zhejiang,China)
出处 《医学信息》 2021年第10期153-155,共3页 Journal of Medical Information
关键词 肺炎克雷伯菌 细菌耐药 药敏试验 Klebsiella pneumoniae Bacterial resistance Drug susceptibility test
  • 相关文献

参考文献7

二级参考文献62

  • 1CLSI. Performance Standards for Antimierobial Susceptibility Testing: Twenty-Fifth Informational Supplement. CLSI document M100-S25. Wayne, PA:CLSI, 2015.
  • 2Clinical and Laboratory Standards Institute.Performance Standards for Antimicrobial Susceptibility Testing [S].Twenty- Fourth Informational Supplement,2014,M100-S24.
  • 3Pifzer Inc.Tygacil? Product Insert.Philadelphia,PA,2013[Z/OL].[2015-04-201.http://www.pfizerpro.com/hcp/tygacil.
  • 4MAGIORAKOS AP,SRINIVASAN A,CAREY RB,et al.Multidrug-resistant,extensively drug-resistant and pandrug- resistant bacteria:an international expert proposal for interim standard definitions for acquired resistance [J].Clin Microbiol Infect,2012,18(3):268-281.
  • 5SHON AS,BAJWA RP,RUSSA TA,et al.Hypervirulent (hypermucoviscous) Klebsiella pneumoniae:a new and dangerous breed[J].Virulence,2013,4(2):107-118.
  • 6LIU YM,LI BB,ZHANG YY,et al.Clinical and molecular characteristics of emerging hypervirulent Klebsiella pneumoniae bloodstream infections in China's Mainland[J].Antimicrob Agents Chemother,2014,58(9):5379-5385.
  • 7TSAKRIS A, POULOU A,THEMELI-DIGALAKI K,et al.Use of boronic acid disk tests to detect extended- spectrum beta- lactamases in clinical isolates of KPC carbapenemase-possessing Enterobacteriaceae[J].J Clin Microbiol,2009,47(11):3420-3426.
  • 8CHONG Y,ITO Y,KAMIMURA T.Genetic evolution and clinical impact in extended-spectrum p-lactamase-producing Escherichia coli and Klebsiella pneumoniae[J].Infect Genet Evol,2011,11(7):1499-1504.
  • 9CURELLO J,MACDOUGALL C,et al.Beyond susceptible and resistant,part II:treatment of infections due to gram-negative organisms producing extended-spectrum p_lactamases[J].J Pediatr Pharmacol Ther,2014,19(3):156-164.
  • 10XU Y,GU B,HUANG M,et al.Epidemiology of carbapenem resistant Enterobacteriaceae (CRE) during 2000-2012 in Asia [J].J Thorac Dis,2015,7(3):376-385.

共引文献206

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部